-
2023, 35(3): 197-232. doi: 10.21147/j.issn.1000-9604.2023.03.01
-
CSCO guidelines for colorectal cancer version 2023: Updates and insights
2023, 35(3): 233-238. doi: 10.21147/j.issn.1000-9604.2023.03.02
-
Challenges and interventions of chimeric antigen receptor-T cell therapy in solid tumors
2023, 35(3): 239-244. doi: 10.21147/j.issn.1000-9604.2023.03.03
-
2023, 35(3): 245-251. doi: 10.21147/j.issn.1000-9604.2023.03.04
-
Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors
2023, 35(3): 252-265. doi: 10.21147/j.issn.1000-9604.2023.03.05
-
2023, 35(3): 266-282. doi: 10.21147/j.issn.1000-9604.2023.03.06
-
Immune evasion and therapeutic opportunities based on natural killer cells
2023, 35(3): 283-298. doi: 10.21147/j.issn.1000-9604.2023.03.07
-
Th1 cells inducing IFNγ response improves immunotherapy efficacy in gastric cancer
2023, 35(3): 299-315. doi: 10.21147/j.issn.1000-9604.2023.03.08
-
2023, 35(3): 316-330. doi: 10.21147/j.issn.1000-9604.2023.03.09
2023 Vol.35 Issue 3
Back Top